Clinical Specialists to Present Clinical Experience at American Burn Association Meeting
ST. PETERSBURG, Fla., March 24 /PRNewswire-FirstCall/ -- Smith & Nephew Inc’s Advanced Wound Management division will host a clinical symposium titled “Optimizing Outcomes in Burn Care” at the 41st Annual Meeting of the American Burn Association. At this symposium, top burn specialists will present their clinical work with Smith & Nephew’s VERSAJET(TM) Hydrosurgery system, ACTICOAT(TM) antimicrobial barrier dressings, and RENASYS(TM) Negative Pressure Wound Therapy products, and their synergistic use of these products to manage complex burn wounds and soft tissue injuries. The symposium begins at 12:15pm on Thursday, March 26th in Room 007AB/Convention Center of the San Antonio Convention Center.
“For more than 150 years, Smith & Nephew has been a leader in wound and burn care, and the company works hard to maintain its exceptional reputation among clinicians for superior products and services,” said Tom Dugan, North American President of Advanced Wound Management at Smith & Nephew. “Smith & Nephew provides a comprehensive platform for the preparation, protection and progression towards healing of complex burns and other soft tissue injuries, helping clinicians at every stage of burn treatment deliver the best possible care, and deliver value to their healthcare institutions.”
The symposium will consist of the following presentations:
“With its broad range of tools for wound management, Smith & Nephew has provided the advanced technology clinicians need for the research and clinical work required to improve patient outcomes, operate more efficiently and reduce the costs of delivering quality care,” said Dr. Cinat. “The addition of a new NPWT solution has been very important. Smith & Nephew’s new RENASYS(TM) foam and gauze wound interfaces provide us with greater clinical choice to select treatment according to the needs of each individual patient. RENASYS(TM) is an efficacious and cost-effective solution and patients find it more comfortable, a critical consideration for patient quality of life and compliance.”
Smith & Nephew will feature its “Prepare, Protect and Progress” Wound Care Platform, which includes the VERSAJET(TM), ACTICOAT(TM) and RENASYS(TM) products, at Booth 101 of the American Burn Association’s 41st Annual Meeting, to be held March 24-27 at the San Antonio Convention Center in San Antonio, Texas.
For more information about Smith & Nephew, please go to www.versajet.info, www.allevyn.com, and www.myrenasys.com.
About Smith & Nephew
Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people’s lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.
Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under “Outlook” are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew’s most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew’s expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
CONTACT: Press: Steve DiMattia, Managing Director, EVC Group, Inc.,
+1-646-201-5445; Investors and Analysts: Liz Hewitt, Group Director
Corporate Affairs, Smith & Nephew, +44 (0)20 7401 7646; Other Inquiries:
Tom Dugan, North American President, Smith & Nephew Advanced Wound
Management, +1-727-399-3743
Web site: http://www.smith-nephew.com/
